TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06428799

Intervention type: DEVICE
Intervention: Carebot AI MMG
Description: Carebot AI MMG is a software solution that utilizes artificial intelligence methods, specifically deep learning and computer vision algorithms, to evaluate and localize suspicious regions of potential lesions during the interpretation of digital breast x-rays as part of standard mammography screening procedures. The Carebot AI MMG medical device is not intended for use in diagnostic mammography. The Carebot AI MMG is intended for use in women over the age of 18.~The predictive outputs of the Carebot AI MMG medical device are intended to aid decision-making in screening clinical practice, always in conjunction with other relevant patient information and based on the professional judgment of the examining clinician. The Carebot AI MMG is specifically designed to provide a supporting layer of analysis that helps in evaluating or prioritizing mammography images with additional patient information and the professional judgment of the examining physician.

Intervention type: DEVICE
Intervention: Carebot AI MMG
Description: Carebot AI MMG is a software solution that utilizes artificial intelligence methods, specifically deep learning and computer vision algorithms, to evaluate and localize suspicious regions of potential lesions during the interpretation of digital breast x-rays as part of standard mammography screening procedures. The Carebot AI MMG medical device is not intended for use in diagnostic mammography. The Carebot AI MMG is intended for use in women over the age of 18.~The predictive outputs of the Carebot AI MMG medical device are intended to aid decision-making in screening clinical practice, always in conjunction with other relevant patient information and based on the professional judgment of the examining clinician. The Carebot AI MMG is specifically designed to provide a supporting layer of analysis that helps in evaluating or prioritizing mammography images with additional patient information and the professional judgment of the examining physician.

Intervention type: DEVICE
Intervention: Carebot AI MMG
Description: Carebot AI MMG is a software solution that utilizes artificial intelligence methods, specifically deep learning and computer vision algorithms, to evaluate and localize suspicious regions of potential lesions during the interpretation of digital breast x-rays as part of standard mammography screening procedures. The Carebot AI MMG medical device is not intended for use in diagnostic mammography. The Carebot AI MMG is intended for use in women over the age of 18.~The predictive outputs of the Carebot AI MMG medical device are intended to aid decision-making in screening clinical practice, always in conjunction with other relevant patient information and based on the professional judgment of the examining clinician. The Carebot AI MMG is specifically designed to provide a supporting layer of analysis that helps in evaluating or prioritizing mammography images with additional patient information and the professional judgment of the examining physician.
Study: NCT04828915

Intervention type: OTHER
Intervention: Machine learning
Description: Machine learning on vital parameters, clinical symptoms and underlying diseases

Intervention type: OTHER
Intervention: Machine based evaluation
Description: Quantification of the prediction power and identification of the most relevant predictive parameters
Study: NCT05815459

Intervention type: DEVICE
Intervention: OCOsense
Description: Volunteers wear OCOsense glasses continuously during testing to monitor biobehavioural responses to tasks

Intervention type: DEVICE
Intervention: OCOsense
Description: Volunteers wear OCOsense glasses continuously during testing to monitor biobehavioural responses to tasks
Study: NCT04872790

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar Puncture
Description: Undergo lumbar puncture

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study: NCT06261359

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CEND-1
Description: CEND-1 will be provided as concentrate for solution to be administered via IV injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine will be provided as solution to be administered via IV infusion.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gemcitabine
Description: Gemcitabine will be provided as solution to be administered via IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Nab-paclitaxel will be provided as solution to be administered via IV infusion.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nab paclitaxel
Description: Nab-paclitaxel will be provided as solution to be administered via IV infusion.
Study: NCT06510010

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin With S-1 (SOX) Combined H. Pylori Eradication (Amoxicillin + clarithromycin + omeprazole + colloidal bismuth subcitrate)
Description: Oxaliplatin With S-1 (SOX) regimen:~S-1: 40mg/m2, oral, bid, D1-14, one cycle every 3 weeks; Oxaliplatin: 130 mg/m2, IV, qd, D1, every 3 weeks for one cycle.~H. pylori eradication regimen:~H. pylori eradication was performed using a quadruple regimen for 14 d. Omeprazole 20 mg bid+Colloidal bismuth subcitrate 220mg bid+Amoxicillin 1g bid+Clarithromycin 500mg bid.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin With S-1 （SOX）
Description: Oxaliplatin With S-1 （SOX） regimen:~S-1: 40mg/m2, oral, bid, D1-14, one cycle every 3 weeks; Oxaliplatin: 130 mg/m2, IV, qd, D1, every 3 weeks for one cycle.
Study: NCT04938882

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Compound lidocaine at low concentration
Description: Before the induction of anesthesia, 0.4% compound lidocaine is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Compound lidocaine at high concentration
Description: Before the induction of anesthesia, 0.6% compound lidocaine is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side
Study: NCT04018521

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PPN
Description: Delivery of Coordinated Specialty Care (CSC) for Y/YA in New York's state program for FEP, called OnTrackNY (OTNY).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CSC Usual Care
Description: standard of care provided to youth following first episode of psychosis

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CSC Usual Care
Description: standard of care provided to youth following first episode of psychosis
Study: NCT06721208

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: use the Move for Knee APP
Description: The mobile APP called Move Your Knee allows the collection of data entered by patients, useful for understanding their lifestyle habits and daily physical activity level, and information relating to KOA pathology.~At the end of the questionnaire, the algorithm integrated into the APP's computer code will allow the calculation of the patient's presumed level of physical activity. This will then be followed by the assignment of a specific form which includes the exercises and the related execution parameters (i.e. weekly frequency), and useful advice for safely carrying out the exercises to achieve the specific functional objectives.
Study: NCT06721468

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trout
Description: rainbow trout

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trout
Description: rainbow trout

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trout
Description: rainbow trout
Study: NCT05131230

Intervention type: DEVICE
Intervention: CytoSorb® treatment
Description: Patients with Acute on Chronic Liver Failure (ACLF) due to Severe Alcoholic Hepatitis in combination with systemic inflammation and ACLF grade ≥2 will be enrolled in this study. Every patient that is screened, fulfills the inclusion/exclusion criteria, and consents to the study, will be allowed to enter the study. Patients will receive Standard of Care treatment for alcoholic hepatitis plus treatment with the CytoSorb® 300 mL device.
Study: NCT04494126

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Drug: Tranexamic Acid Injectable Solution the drug will be given to patients intravenously at a dose of 10mg/kg pre-operatively after induction on general anesthesia before incision.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Other: Placebo (normal saline 0.9%) An equivalent amount of normal saline (0.9%) will be given to the patient pre-operatively after induction of general anesthesia. The amount of saline given will correspond to the same amount of fluid which would have been given had the patient been in the intervention group.
Study: NCT06583603

Intervention type: BEHAVIORAL
Intervention: Barriers to Implementing Sensory Strategies Survey
Description: Survey, see arm description
Study: NCT06584214

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Diagnostic test: Determine™ Syphilis Advanced test
Description: The Determine™ Syphilis Advanced test is intended as an aid in detecting antibodies to Treponema pallidum in individuals with current or past infection.
Study: NCT06584175

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet Delivered Cognitive Behavioural Therapy
Description: The tinnitus ICBT program consists of 1) an overview of tinnitus, depression, and anxiety; 2) managing unhelpful thoughts and learning problem solving strategies association with pain, anxiety, depression, and disability; 3) management of common symptoms associated with tinnitus, anxiety, and depression; 4) developing strategies to maintain activities while minimizing fatigue; and 5) strategies to improve quality of life through effective goal setting. Supplementary lessons can be accessed at any time (e.g., sleep, communication, problem solving, assertiveness training). Materials are presented in a didactic (i.e., text-based and audio with visual images) and case-enhanced learning format (i.e., stories demonstrate the application of skills). Case vignettes that specifically reflect the experiences of those with tinnitus are included.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Internet Delivered Cognitive Behavioural Therapy
Description: The tinnitus ICBT program consists of 1) an overview of tinnitus, depression, and anxiety; 2) managing unhelpful thoughts and learning problem solving strategies association with pain, anxiety, depression, and disability; 3) management of common symptoms associated with tinnitus, anxiety, and depression; 4) developing strategies to maintain activities while minimizing fatigue; and 5) strategies to improve quality of life through effective goal setting. Supplementary lessons can be accessed at any time (e.g., sleep, communication, problem solving, assertiveness training). Materials are presented in a didactic (i.e., text-based and audio with visual images) and case-enhanced learning format (i.e., stories demonstrate the application of skills). Case vignettes that specifically reflect the experiences of those with tinnitus are included.
Study: NCT06721468

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trout
Description: rainbow trout
Study: NCT05052567

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CEND-1
Description: The dose is specified according to the protocol. CEND-1+paclitaxel (albumin-bound type)+gemcitabine
Study: NCT05132751

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Machine Learning Ventilator Decision System
Description: Artificial intelligence ventilator system for personalized mechanical ventilation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Machine Learning Ventilator Decision System
Description: Artificial intelligence ventilator system for personalized mechanical ventilation
Study: NCT06519903

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BREATH technique
Description: The BREATH techniques include deep breathing, rapid breathing, and alternate nostril breathing exercises. Participants were first instructed on the breathing exercises (at the lowest point of breathing, close the left nostril with the right index finger and exhale through the right nostril): Breathe in through the right nostril, then close it with your thumb and breathe out through the left nostril. This cycle was repeated at least three more times.
Study: NCT05579938

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Enzyme-containing lozenge
Description: A lozenge containing 3 active enzymes

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo lozenge
Description: Identical placebo lozenge
Study: NCT04647682

Intervention type: OTHER
Intervention: physical activity program
Description: * 30 second chair test,~* balance with joint-feet and semi-tandem stance~* 4 meters comfortable walking test were evaluated
Study: NCT05360719

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group tele-exercise
Description: This tele-exercise class will be tailored to the physical and emotional needs of individuals with SCI based on results of our feasibility study, the initial emergent themes from qualitative data collection in this study, and input from our co-leader with lived experience (examples: seated exercise to accommodate wheelchair users, active co-leader with SCI).The research clinician will lead the instruction of each class while our co-leader will model movements alongside her and offer tailored modifications as needed. Each 45-minute class provides a comprehensive fitness experience to maximize functional independence and improve global physical activity engagement. Elements incorporated into each class session include a collective check-in and breathing meditation, postural control, trunk and shoulder strength, cardiovascular fitness, and body awareness.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Group tele-exercise
Description: This tele-exercise class will be tailored to the physical and emotional needs of individuals with SCI based on results of our feasibility study, the initial emergent themes from qualitative data collection in this study, and input from our co-leader with lived experience (examples: seated exercise to accommodate wheelchair users, active co-leader with SCI).The research clinician will lead the instruction of each class while our co-leader will model movements alongside her and offer tailored modifications as needed. Each 45-minute class provides a comprehensive fitness experience to maximize functional independence and improve global physical activity engagement. Elements incorporated into each class session include a collective check-in and breathing meditation, postural control, trunk and shoulder strength, cardiovascular fitness, and body awareness.
Study: NCT05933668

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: YK0901 cells
Description: On day 0, the TCR-T cells will be administered one time. Drug: Fludarabine + Cyclophosphamide+Oxaliplatin Fludarabine: 25mg/m²/day×3days Cyclophosphamide: 300mg/m²/day×3 days Oxaliplatin：100mg×1day Drug: IL-2 After 18-24 hours of infusion of YK0901 cells, the patients will be given a small dose of IL-2 subcutaneously, 500,000 IU/time, twice a day (interval 10-12 hours), for 14 days.
Study: NCT05240001

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thulium Fibre Laser
Description: Participants will undergo treatment using the TFL

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MOSES Holmium Laser
Description: Participants will undergo treatment using the MOSES Holmium laser.
Study: NCT06038734

Intervention type: DIAGNOSTIC_TEST
Intervention: gastric ultrasound
Description: Utilize POC gastric ultrasound to identify the presence of retained gastric contents.

Intervention type: DIAGNOSTIC_TEST
Intervention: gastric ultrasound
Description: Utilize POC gastric ultrasound to identify the presence of retained gastric contents.
Study: NCT06547255

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine liposome injectable suspension
Description: At the end of the third molar extraction surgical procedure performed under general anesthesia and at least fifteen minutes following the most recent administration of 2% lidocaine with 1:100,000 epinephrine nerve block (routine for this procedure), all patients will receive bilateral infiltrations with 3mL of 1.3% liposomal bupivacaine (Exparel) OR with 3mL of 0.5% bupivacaine with 1:200,000 epinephrine while they are still under general anesthesia.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine liposome injectable suspension
Description: At the end of the third molar extraction surgical procedure performed under general anesthesia and at least fifteen minutes following the most recent administration of 2% lidocaine with 1:100,000 epinephrine nerve block (routine for this procedure), all patients will receive bilateral infiltrations with 3mL of 1.3% liposomal bupivacaine (Exparel) OR with 3mL of 0.5% bupivacaine with 1:200,000 epinephrine while they are still under general anesthesia.
Study: NCT06584305

Intervention type: PROCEDURE
Intervention: AI-Powered Body Dysmorphic Disorder Screening Procedure
Description: The AI-Powered Body Dysmorphic Disorder Screening Procedure involves using an AI tool to evaluate patients for Body Dysmorphic Disorder (BDD) before undergoing elective cosmetic surgery. The screening integrates the Body Dysmorphic Disorder Questionnaire (BDDQ) with additional psychological assessments. The AI system processes the collected data to produce a risk score, guiding surgeons in making informed decisions about the need for psychological evaluation or intervention, and determining the suitability of patients for surgery.
Study: NCT06205082

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LIT-00814
Description: LIT-00814 is an oral tablet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LIT-00814
Description: LIT-00814 is an oral tablet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LIT-00814
Description: LIT-00814 is an oral tablet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LIT-00814
Description: LIT-00814 is an oral tablet.
Study: NCT04625764

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sampling and analysis
Description: Blood sampling for pharmacokinetics (Plasma ticagrelor concentrations and its metabolite) and MEA platform testing (ADPtest, TRAPtest)
Study: NCT04091243

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Romosozumab
Description: Experimental drug for the treatment of glucocorticoid induced osteoporosis

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romosozumab
Description: Experimental drug for the treatment of glucocorticoid induced osteoporosis
Study: NCT05985967

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBMT-sMF
Description: PBMT-sMF applied in the lower limbs with different doses per muscle group.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Shock wave
Description: Shock wave therapy applied in the lower limbs for 30 minutes.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pneumatic compression
Description: Pneumatic compression applied in the lower limbs for 30 minutes.
Study: NCT06721468

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trout
Description: rainbow trout

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Child-centered nutrition phrases
Description: learn the phrase, trout helps your brain so you can learn and play either through researcher introduction or completing the About Trout! Pond to Plate curriculum

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Child-centered nutrition phrases
Description: learn the phrase, trout helps your brain so you can learn and play either through researcher introduction or completing the About Trout! Pond to Plate curriculum
Study: NCT05985967

Intervention type: OTHER
Group type: OTHER
Intervention: Passive recovery
Description: Volunteers laid in supine position resting for 30 minutes.
Study: NCT04565795

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Uriprene® Degradable Temporary Ureteral Stent
Description: Assess adequate intervention-free drainage during use and the time to complete degradation or the passage of stent fragments/segments from the urinary system by radiological assessment.
Study: NCT06168617

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Performance tasks in daily life
Description: Evaluation of performance tests executed by patients in real-life situations.
Study: NCT05863637

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive Short-Term Dynamic Psychotherapy
Description: A dynamic and intensive psychotherapy with eight therapeutic sessions
Study: NCT05334901

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High intensity light cure
Description: Bulk fill resin composite restoration cured with high intensity light curing (2200 mw/cm2)To achieve increased power and a wider spectrum for short exposure time (1 second) to overcome resin composite restoration techniques sensitivity and shorten the clinical procedure

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High intensity light cure
Description: Bulk fill resin composite restoration cured with high intensity light curing (2200 mw/cm2)To achieve increased power and a wider spectrum for short exposure time (1 second) to overcome resin composite restoration techniques sensitivity and shorten the clinical procedure
Study: NCT05773547

Intervention type: DEVICE
Intervention: MSOT measurements
Description: Non-invasive transcutaneous imaging of subcellular muscle components via infrared and near-infrared laser pulses

Intervention type: DEVICE
Intervention: MSOT measurements
Description: Non-invasive transcutaneous imaging of subcellular muscle components via infrared and near-infrared laser pulses

Intervention type: DEVICE
Intervention: MSOT measurements
Description: Non-invasive transcutaneous imaging of subcellular muscle components via infrared and near-infrared laser pulses

Intervention type: DEVICE
Intervention: MSOT measurements
Description: Non-invasive transcutaneous imaging of subcellular muscle components via infrared and near-infrared laser pulses
Study: NCT04877938

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Echolgical physical activity Intervention
Description: 'Ecological-Exercise-Intervention'(EEI), would be to limit sitting time to no more than 2 hours/day, and to stand up and move after 30 minutes of continuous sitting. In accordance with several epidemiologic evidences light-intensity activities would be encouraged to substitute sedentary time (e.g., standing up while talking on the telephone, ironing while watching TV).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Echolgical physical activity Intervention
Description: 'Ecological-Exercise-Intervention'(EEI), would be to limit sitting time to no more than 2 hours/day, and to stand up and move after 30 minutes of continuous sitting. In accordance with several epidemiologic evidences light-intensity activities would be encouraged to substitute sedentary time (e.g., standing up while talking on the telephone, ironing while watching TV).